Freeform announces they have two new dramas in development, Cleopatra, their first-ever period piece and Augs, as in augmented, a sci-fi series set in the near future that sounds a lot like Scott Westerfeld’s Uglies series.
Cleopatra will be an epic, female-centric adventure series following the life of the most beloved ruler in Egyptian history, Cleopatra, who after being exiled as a young woman decides to stand up against the patriarchy and fight back for her freedom and rightful place as heir. This tale will follow her rise and transition to becoming not only the first, last and only female Pharaoh, but also the world’s most powerful person all while engaging in a classic love triangle that changed the map of the world forever. Cleopatra is produced by ABC Signature Studios and executive produced by Michael Sietzman (“Quantico,” “Code Black”), Christina Davis, Lorenzo di Bonaventura, Daniel McDermott and Mike Weiss.
Created and directed by Scott Stewart (Blumhouse’s “Dark Skies”), Augs is set in the all-to-near future when society is divided into two classes: Augs, the privileged who can afford the latest technological-biological enhancements that provide an always-connected augmented reality view of the world; and Norms, the disenfranchised rest who’ve become a nearly invisible underclass. Set in the moneyed, suburban enclave of Cambio Point, Augs follows Gennifer Wells, an ambitious and popular Aug girl, who falls in love with Bodhi Bright, the mysterious new guy in town. The only problem is he’s a Norm, and this causes her friends and family to turn against her. As she realizes being enhanced isn’t all it’s cracked up to be, Gennifer is forced to make a choice between the privileged augmented world she knows and the strange boy she loves, who prefers to see things through his “unenhanced” eyes. But her choice will not be easy, as forces on both sides conspire to keep them apart. Stewart and Anonymous Content’s Jeff Okin will produce.
No casting or debut date info yet, but keep your eyes on this site for updates.